Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome

Background and Objectives In vitro studies suggest that thalidomide has an immunoregulatory role and alters the marrow microenvironment. We assessed laboratory and clinical parameters in patients with myeloma treated with thalidomide as potential prognostic markers and looked for changes with therap...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Linda Mileshkin, Dirk Honemann, Peter Gambell, Melanie Trivett, Yoshihiro Hayakawa, Mark Smyth, Victoria Beshay, David Ritchie, Paul Simmons, Alvin D. Milner, Jerome B. Zeldis, H. Miles Prince
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2007-08-01
Colecção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/4536
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!